Fundraising Fox

Corindus Vascular Robotics

Waltham, US · Founded 2011 · Delaware corporation · 2 known investors

Founders & leadership

SJ
Stephen J. LemasterExecutive
MJ
Mark J. TolandExecutive
DW
David W. LongExecutive
JC
Jeffrey C LightcapChairman
DW
David W LongNamed on SEC filing
MM
Michael MashaalNamed on SEC filing
JG
Jeffrey GoldNamed on SEC filing
DM
David M HandlerNamed on SEC filing
DW
David WhiteNamed on SEC filing

Board

JC
Jeffrey C. LightcapBoard director
LA
Louis A. CannonBoard director
GW
Gerard WinkelsBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$117.1M disclosed across 7 rounds · 2014–2019

$4.8MraisedMar 2019 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas TeanyExecutive Officer
  • Nathan R. HarringtonDirector
  • James R. TobinDirector
  • Campbell D. RogersDirector
  • David W. LongExecutive Officer
  • Mark J. TolandExecutive Officer, Director
  • Douglas L. BraunsteinDirector
  • Jeffrey G. GoldDirector
  • Louis A. CannonDirector
  • Jeffrey C. LightcapDirector
Offering amount
$4.8M
Amount sold
$4.8M
First sale
Mar 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$413.9KraisedMar 2019 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas TeanyExecutive Officer
  • Campbell D. RogersDirector
  • Nathan R. HarringtonDirector
  • Douglas L. BraunsteinDirector
  • Jeffrey C. LightcapDirector
  • Jeffrey G. GoldDirector
  • Mark J. TolandExecutive Officer, Director
  • David W. LongExecutive Officer
  • James R. TobinDirector
  • Louis A. CannonDirector
Offering amount
$413.9K
Amount sold
$413.9K
First sale
Mar 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$15MraisedMar 2019 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey C. LightcapDirector
  • Douglas TeanyExecutive Officer
  • David W. LongExecutive Officer
  • Campbell D. RogersDirector
  • James R. TobinDirector
  • Nathan R. HarringtonDirector
  • Douglas L. BraunsteinDirector
  • Mark J. TolandExecutive Officer, Director
  • Louis A. CannonDirector
  • Jeffrey G. GoldDirector
Offering amount
$15M
Amount sold
$15M
First sale
Feb 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$25MraisedMar 2018 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey G. GoldDirector
  • Douglas L. BraunsteinDirector
  • Campbell D. RogersDirector
  • Nthan R. HarringtonDirector
  • Jeffrey C. LightcapDirector
  • Mark J. TolandExecutive Officer, Director
  • David W. LongExecutive Officer
  • Louis A. CannonDirector
  • James R. TobinDirector
Offering amount
$25M
Amount sold
$25M
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$180KraisedMar 2018 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas L. BraunsteinDirector
  • James R. TobinDirector
  • Jeffrey C. LightcapDirector
  • Jeffrey G. GoldDirector
  • Nathan R. HarringtonDirector
  • Campbell D. RogersDirector
  • Louis A. CannonDirector
  • David W. LongExecutive Officer
  • Mark J. TolandExecutive Officer, Director
Offering amount
$180K
Amount sold
$180K
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$45MraisedMar 2017 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey C. LightcapDirector
  • Campbell D. RogersDirector
  • Stephen J. LemasterExecutive Officer
  • Louis A. CannonDirector
  • Mark J. TolandExecutive Officer, Director
  • Jeffrey G. GoldDirector
  • David W. LongExecutive Officer
  • Gerard WinkelsDirector
Offering amount
$45M
Amount sold
$45M
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$26.7MraisedSep 2014 · 15 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • Jeffrey C LightcapDirector
  • David W LongExecutive Officer
  • Michael MashaalDirector
  • Jeffrey GoldDirector
  • David M HandlerExecutive Officer, Director
  • Gerard WinkelsDirector
  • Hillel BachrachDirector
  • David WhiteDirector
Offering amount
$26.7M
Amount sold
$26.7M
Minimum investment
$100K
Sales commissions
$1M
Placement agents
Cowen and Company, LLC, Stifel, Nicolaus & Company, Incorporated
First sale
Sep 2014
Incorporated
Corporation, Nevada, 2011
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Corindus Vascular Robotics's investors?
Corindus Vascular Robotics's investors include 20/20 HealthCare Partners LLC, BioStar Ventures.
How much funding has Corindus Vascular Robotics raised?
Corindus Vascular Robotics has disclosed $117.1M raised across 7 rounds.
Where is Corindus Vascular Robotics headquartered?
Corindus Vascular Robotics is headquartered in Waltham, US.